Effects of safinamide adjunct therapy on non-motor symptoms in patients with Parkinson's disease: a post-hoc analysis of the Japanese Phase 2/3 study

被引:0
|
作者
Hattori, N.
Tsuboi, Y.
Kogo, Y.
Koebisu, M.
Ishida, T.
Suzuki, I.
Nomoto, M.
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
393
引用
收藏
页码:S174 / S175
页数:2
相关论文
共 50 条
  • [1] The Effects of Safinamide Adjunct Therapy on Depression and Apathy in Patients With Parkinson's Disease: Post-hoc Analysis of a Japanese Phase 2/3 Study
    Hattori, Nobutaka
    Kogo, Yuki
    Koebis, Michinori
    Ishida, Takayuki
    Suzuki, Ippei
    Tsuboi, Yoshio
    Nomoto, Masahiro
    FRONTIERS IN NEUROLOGY, 2022, 12
  • [2] Effects of safinamide adjunct therapy on pain in patients with Parkinson's disease: Post hoc analysis of a Japanese phase 2/3 study
    Tsuboi, Yoshio
    Koebis, Michinori
    Kogo, Yuki
    Ishida, Takayuki
    Suzuki, Ippei
    Nomoto, Masahiro
    Hattori, Nobutaka
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [3] Characteristics of wearing-off and motor symptoms improved by safinamide adjunct therapy in patients with Parkinson's disease: A post hoc analysis of a Japanese phase 2/3 study
    Nomoto, Masahiro
    Ishida, Takayuki
    Koebis, Michinori
    Kamei, Takanori
    Suzuki, Ippei
    Hattori, Nobutaka
    Tsuboi, Yoshio
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2022, 434
  • [4] Safinamide as an adjunct to Levodopa Therapy in Asian and Caucasian Patients with Parkinson's Disease and Motor Fluctuations: A post-hoc Analysis of the SETTLE study
    Bhidayasiri, R.
    Ishida, T.
    Husni, R. E.
    Kamei, T.
    Suzuki, I.
    Wu, S. L.
    Cho, J. W.
    MOVEMENT DISORDERS, 2022, 37 : S320 - S320
  • [5] The effect of exenatide on specific non-motor symptoms in Parkinson's disease - a post-hoc analysis
    Athauda, D.
    Budnik, N.
    Chowdhury, K.
    Skene, S.
    Foltynie, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 309 - 309
  • [6] Effects of Safinamide on Motor and Non-Motor Symptoms in Patients with Parkinson's Disease and Motor Fluctuations
    Kulisevsky, Jaime
    Ferraz, Henrique B.
    Suppa, Antonio
    Reichmann, Heinz
    EUROPEAN NEUROLOGY, 2024, 87 (5-6) : 291 - 305
  • [7] Long-term effects of safinamide adjunct therapy on levodopa-induced dyskinesia in Parkinson’s disease: post-hoc analysis of a Japanese phase III study
    Nobutaka Hattori
    Takanori Kamei
    Takayuki Ishida
    Ippei Suzuki
    Masahiro Nomoto
    Yoshio Tsuboi
    Journal of Neural Transmission, 2022, 129 : 1277 - 1287
  • [8] Long-term effects of safinamide adjunct therapy on levodopa-induced dyskinesia in Parkinson's disease: post-hoc analysis of a Japanese phase III study
    Hattori, Nobutaka
    Kamei, Takanori
    Ishida, Takayuki
    Suzuki, Ippei
    Nomoto, Masahiro
    Tsuboi, Yoshio
    JOURNAL OF NEURAL TRANSMISSION, 2022, 129 (10) : 1277 - 1287
  • [9] Effects of Safinamide on Pain in Fluctuating Parkinson's Disease Patients: A Post-Hoc Analysis
    Cattaneo, Carlo
    Barone, Paolo
    Bonizzoni, Erminio
    Sardina, Marco
    JOURNAL OF PARKINSONS DISEASE, 2017, 7 (01) : 95 - 101
  • [10] Correction: Long-term effects of safinamide adjunct therapy on levodopa-induced dyskinesia in Parkinson’s disease: post-hoc analysis of a Japanese phase III study
    Nobutaka Hattori
    Takanori Kamei
    Takayuki Ishida
    Ippei Suzuki
    Masahiro Nomoto
    Yoshio Tsuboi
    Journal of Neural Transmission, 2022, 129 : 1393 - 1394